Definitive Contract HHSN271201600021C
Award Date
9/13/16
Potential Completion Date
12/14/18
Potential Value
$1.5M
Federal Agency
National Institute on Drug Abuse
Awardee
Cairn Biosciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94158, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $229,893.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract is for the development of a "MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS." The contract is a definitive, firm-fixed price contract with a completion date of May 14, 2017.</p>
<p>The National Center for Advancing Translational Sciences, a civilian agency, awarded a Firm Fixed Price definitive contract worth $225,000.00 to Cairn Biosciences Inc., a Woman Owned Small Business, for the development of a "MULTIPLEXED HIGH CONTENT ASSAY TO MEASURE ENDOPLASMIC RETICULUM STRESS FOR PREDICTIVE TOXICOLOGY". The contract has a total small business set-aside and is scheduled for completion by March 14, 2016.</p>
This federal contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Cairn Biosciences Inc., a woman-owned small business, for the development of a microfluidic-enabled smartplate for precision culture, control, and monitoring of living cells. The contract, awarded under the Small Business Innovation Research (SBIR) Program Phase II, has a firm fixed price of $1,499,968.00 and a completion date of May 31, 2020. The contract was...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Small Business Innovation Research (SBIR) Phase I contract to Cairn Biosciences Inc., a woman-owned small business, for the development of a microfluidic and machine learning-enabled smart laboratory system for autonomous remote execution and iteration of multiscale live cell assays for drug discovery. The firm-fixed-price contract has a potential value of...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract, valued at $230,000.00, is for the development of a "Multifunctional, Reusable and Automated Microfluidic Smart Plate for High Throughput Live Cell Assays". The contract has a Firm Fixed Price pricing type and a period of performance ending on February...
This is a $3,859,150.11 Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract was set aside for sole-source award under the 8(a) program. It involves procuring scientific and laboratory equipment such as mass spectrometers, liquid chromatography systems,...
This is a $1,499,871.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Scitech Strategies Inc., a for-profit, Subchapter S Corporation small business. The contract is for the creation of an accurate model of the topical structure of PubMed and associated indicators, with a period of performance from September 30, 2018 to September 29, 2020. This contract is a Small Business Innovation Research (SBIR) Program Phase II action.
This is a $1,650,550.13 time and materials delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Capital Consulting Corp, a minority-owned, woman-owned, veteran-owned small business located in Fairfax, Virginia. The contract is for the NIDA Intramural Research Program (NIDA IRP) Clinical Program Support, which includes participant remuneration, travel, and subsistence. The period of performance is from November 1, 2023 to October 31, 2024, with a...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
<p>This is a $113,258.16 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Maris Solutions LLC, a small disadvantaged woman-owned business. The contract has a period of performance ending on February 29, 2016, and was awarded on August 31, 2015. The contract does not have a set-aside designation. The contract award does not reference a larger contract vehicle.</p>